Organtransplanterede patienter har behov for intensiv kontrol og behandling af hudcancer

Ugeskrift for Laeger

Volumn 175, Issue 20, 2013, Pages 1408-1411

  Togsverd Bo, Katrine ^a   Sørensen, Søren Schwartz ^b   Hædersdal, Merete ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ACTINIC KERATOSIS; ARTICLE; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; ORGAN TRANSPLANTATION; PATHOLOGY; RISK FACTOR; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION;

CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KERATOSIS, ACTINIC; ORGAN TRANSPLANTATION; RISK FACTORS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84878623082     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. www.scandiatransplant.org (6. mar 2012).
2. Dansk Nefrologisk Selskabs Landsregister Årsrapport 2010. http://www.nephrology. dk/Publikationer/Landsregister/%C3%85rsrapport%202010.pdf (7. jun 2011).
3. Collett D, Mumford L, Banner NR et al. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant 2010;10:1889-96.
4. Moloney FJ, Comber H, O'Lorcain P et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006;154:498-504.
5. Jensen AO, Svaerke C, Farkas D et al. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark. Acta Derm Venereol 2010;90:474-9.
6. Ramsay HM, Fryer AA, Hawley CM et al. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 2002;147:950-6.
7. Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. J Am Acad Dermatol 2011;65:253-61.
8. Murphy GM. Ultraviolet radiation and immunosuppression. Br J Dermatol 2009;161(suppl 3):90-5.
9. Bouwes JNB, Euvrard S, Naldi L et al. Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 2007;127:1647-56.
10. Wisgerhof HC, Edelbroek JR, de Fijter JW et al. Trends of skin diseases in organtransplant recipients transplanted between 1966 and 2006: a cohort study with follow-up between 1994 and 2006. Br J Dermatol 2010;162:390-6.
11. Hofbauer GF, Bouwes JNB, Euvrard S. Organ transplantation and skin cancer: basic problems and new perspectives. Exp Dermatol 2010;19:473-82.
12. Ingvar Å, Smedby KE, Lindelöf B et al. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma. Nephrol Dial Transpl 2010;25:2764-71.
13. Alberu J, Pascoe MD, Campistol JM et al. Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial. Transplantation 2011;92:303-10.
14. Holdaas H, Rostaing L, Seron D et al. Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. Transplantation 2011;92:410-8.
15. McLaughlin-Drubin ME, Munger K. The human papillomavirus E7 oncoprotein. Virology 2009;384:335-44.
16. Proby CM, Harwood CA, Neale RE et al. A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant 2011;11:1498-508.
17. Dansk Dermatologisk Selskab. Retningslinier for kontrol og behandling af nonmelanom hudkræft og forstadier hertil hos organtransplanterede patienter. www.dds.nu/doc/instruks (26. mar 2012).
18. Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011;65:263-79.
19. Horn J, Lock-Andersen J, Rasmussen K et al. Screening for hudcancer hos organtransplanterede patienter i Danmark. Ugeskr Læger 2005;167:25-31.
20. Cramer E, Rasmussen K, Jemec G. Patienters viden om risikoen for hudcancer efter nyretransplantation. Ugeskr Læger 2009;171:3341-5.
21. Ismail F, Mitchell L, Casabonne D et al. Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness. Br J Dermatol 2006;155:916-25.
22. Ulrich C, Jurgensen JS, Degen A et al. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 2009;161(suppl 3):78-84.
23. Sundhedsstyrelsen. Skru ned for solen. www.sst.dk/Sundhed%20og%20forebyggelse/ Solbeskyttelse.aspx (26. mar 2012).